Clinical Trials Logo

Diabetic Foot Osteomyelitis clinical trials

View clinical trials related to Diabetic Foot Osteomyelitis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05539963 Recruiting - Clinical trials for Diabetic Foot Osteomyelitis

A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis of the Forefoot.

BLADE-VG2
Start date: January 23, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to evaluate the safety and between-group effect size of STIMULAN VG compared to SoC treatment in patients with diabetic foot osteomyelitis (DFO) of the forefoot.

NCT ID: NCT05177107 Recruiting - Osteomyelitis Clinical Trials

Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

DANCE
Start date: November 24, 2021
Phase: Phase 2
Study type: Interventional

This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.

NCT ID: NCT02927678 Recruiting - Clinical trials for Diabetic Foot Osteomyelitis

White Blood Cell SPECT/CT and Diabetic Foot Osteomyelitis

Start date: January 2014
Phase: N/A
Study type: Observational

Osteomyelitis is a risk factor for lower extremity amputation in diabetic people. Antibiotic therapy allows a remission in 60 to 80% of cases. However the optimal duration of antibiotic therapy remains controversy due to the absence of validated marker of osteomyelitis remission. We have previously shown that the negativity of white blood cell SPECT/CT (Single Photon Emission Computed Tomography/Computed Tomography) imaging at the end of treatment allowed to predict remission of osteomyelitis at 1 year in all cases. A positive imaging was associated with recurrence in 70% of cases. The aim of our study was to evaluate prospectively the interest of white blood cell SPECT/CT to set the duration of antibiotic therapy.